Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial
| Autor: | Maranda, Bruno *, *, Labbé, Sébastien M *, Lurquin, Magali, Brabant, Pascal, Fugère, Alexandre, Larrivée, Jean-François, Grbic, Djordje, Leroux, Annie, Leduc, Frédéric, Finzi, Andrés, Gaudreau, Simon, Swart, Yolandi |
|---|---|
| Zdroj: | In The Lancet Infectious Diseases January 2024 24(1):25-35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|